Goserelin acetate
SIGMA/G4919 - ≥99% (HPLC), white, powder
Synonym: [D-Ser(tBu)6,Azagly10]-LHRH acetate salt
CAS Number: 145781-92-6
Empirical Formula (Hill Notation): C59H84N18O14
Molecular Weight: 1269.41
MDL Number: MFCD01747329
Linear Formula: C59H84N18O14
Product Type: Chemical
| assay | ≥99% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C59H84N18O14.C2H4O2/c1 |
| InChI key | IKDXDQDKCZPQSZ-JHYYTBFNSA |
| Quality Level | 200 ![]() |
| shipped in | dry ice |
| SMILES string | CC(O)=O.CC(C)C[C@H](NC(=O |
| solubility | H2O: 20 mg/mL, clear, colorless |
| storage temp. | −20°C |
| UniProt accession no. | P55248 ![]() |
P01148 ![]() |
|
P07490 ![]() |
|
P13562 ![]() |
|
P30968 ![]() |
|
P30969 ![]() |
|
Q01776 ![]() |
| Amino Acid Sequence: | Glp-His-Trp-Ser-Tyr-Ser(t |
| Biochem/physiol Actions: | Goserelin acetate peptide results in significant inhibition of gonadotropin release and suppresses steroidogenesis in ovaries and testis. Thus, it leads to a reduction of testosterone to castration levels and estrogen to postmenopausal levels. Therefore, this peptide is used for reducing testosterone levels in patients with locally advanced prostate cancer. |
| Biochem/physiol Actions: | Goserelin is a synthetic analog of LHRH (leutinizing hormone releasing hormone). Goserelin is a LHRH agonist It is used in prostate cancer and breast cancer therapies and also in the treatment of endometriosis. |
| General description: | Goserelin acetate is a synthetic decapaptide, which is a potent analog of LHRH (luteinizing hormone releasing hormone). |
| General description: | Goserelin is used to guard ovary during breast-cancer adjuvant chemotherapy. |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H360 |
| Precautionary statements | P201 - P280 - P308 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥99% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 51111800 |


